Inhaled mometasone furoate reduces oral prednisone requirements while improving respiratory function and health-related quality of life in patients with severe persistent asthma
- 30 November 2000
- journal article
- clinical trial
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 106 (5) , 852-860
- https://doi.org/10.1067/mai.2000.110798
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Pharmaceutically-based severity stratification of an asthmatic populationRespiratory Medicine, 1999
- Effects of fluticasone propionate, triamcinolone acetonide, prednisone, and placebo on the hypothalamic-pituitary-adrenal axisJournal of Allergy and Clinical Immunology, 1999
- Fluticasone propionate powder: Oral corticosteroid–sparing effect and improved lung function and quality of life in patients with severe chronic asthmaJournal of Allergy and Clinical Immunology, 1999
- Oral Glucocorticosteroid-Sparing Effect of Budesonide Administered by TurbuhalerChest, 1998
- Effects of budesonide by means of the Turbuhaler on the hypothalmic-pituitary-adrenal axis in asthmatic subjects: A dose-response studyJournal of Allergy and Clinical Immunology, 1998
- Efficacy and Safety of Inhaled CorticosteroidsAmerican Journal of Respiratory and Critical Care Medicine, 1998
- Topical MometasoneDrugs, 1998
- A placebo- and active-controlled randomized trial of prophylactic treatment of seasonal allergic rhinitis with mometasone furoate aqueous nasal sprayJournal of Allergy and Clinical Immunology, 1996
- Once Daily Mometasone Furoate Aqueous Nasal Spray Is As Effective as Twice Daily Beclomethasone Dipropionate for Treating Perennial Allergic Rhinitis PatientsAnnals of Allergy, Asthma & Immunology, 1996
- Fluticasone propionate reduces oral prednisone use while it improves asthma control and quality of life.American Journal of Respiratory and Critical Care Medicine, 1995